The UK plans to test US firm Eli Lilly’s weight-loss jab Mounjaro to help the burden on the national health care system. Over a quarter of UK adults suffered from obesity in 2023, according to government data.
The United Kingdom plans to trial the use of weight-loss drugs to help unemployed people with obesity get back to work, British Health Minister Wes Streeting said on Tuesday.
London’s plans to test US firm Eli Lilly’s Mounjaro jab comes amid the rising popularity of the diabetes medication Ozempic and Wegovy from Danish pharma giant Novo Nordisk to treat obesity.
DW News - News Source Context (Click to view Full Report)
Information for DW News:
Search topics on Ground.News
https://www.dw.com/en/wegovy-weight-loss-the-science-and-the-hype-of-supplements/a-70346661
https://www.dw.com/en/overweight-and-obesity/t-64918529
https://www.dw.com/en/uk-plans-weight-loss-drug-trials-to-get-people-back-to-work/a-70504242
Media Bias Fact Check | bot support